Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity

Status:
Active, not recruiting

Trial end date:
2022-05-02

Target enrollment:

Participant gender:

The study aims to assess the safety and tolerability of AMG 133 as single and multiple doses in participants with obesity

Phase 1

Amgen